SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-233265
Filing Date
2017-07-24
Accepted
2017-07-24 08:08:42
Documents
3
Period of Report
2017-07-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d430894d8k.htm 8-K 16968
2 EX-10.1 d430894dex101.htm EX-10.1 38213
3 GRAPHIC g430894gra-1.jpg GRAPHIC 24396
  Complete submission text file 0001193125-17-233265.txt   90183
Mailing Address 840 MEMORIAL DRIVE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE 4TH FLOOR CAMBRIDGE MA 02139 617-401-0011
Dimension Therapeutics, Inc. (Filer) CIK: 0001592288 (see all company filings)

IRS No.: 463942159 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37601 | Film No.: 17977568
SIC: 2836 Biological Products, (No Diagnostic Substances)